2025-02-06 Advanced Instruments HaiPress

The OsmoPRO® MAX Automated Osmometerdelivers the automation and data management capabilities required by modern clinical labs.
NORWOOD,Mass.,Jan. 27,2025 -- Advanced Instruments,the leading supplier in osmolality testing,announces the newest update to its clinical line of freezing point osmometers. The OsmoPRO® MAX is designed for clinical laboratories of all sizes seeking enhanced productivity through automation. The instrument uses innovative flow-through technology to eliminate manual pipetting and reduce the use of consumables,allowing testing to begin with the single push of a button.

OsmoPRO® MAX Automated Osmometer
TheOsmoPRO MAX goes beyond providing accurate and precise test results to deliver a complete solution that simplifies the osmolality testing workflow. The instrument delivers increased efficiency through direct sampling from primary tubes without transfer to sample cups,automated barcode scanning to reduce transcription errors,and the capability to upload data to the AdvancedQC peer group program for Advanced Instruments' Protinol® and Renol® matrix-based controls.
Like all Advanced Instruments osmometers,the OsmoPRO MAX uses the industry-preferred freezing point depression method to deliver reliable osmolality results in minutes. The instrument is automatically cleaned with system fluid after each test to minimize the need for user intervention. New samples can be loaded continuously as they arrive,eliminating the need for batch testing.
"The OsmoPRO MAX delivers the usability,automation,and data management features sought by today's clinical laboratories," said Byron Selman,CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that customers have experienced with our osmometers for the past 70 years."
About Advanced Instruments
Advanced Instruments,LLC,is a leading supplier of instrumentation for clinical,pharmaceutical,biotechnology,microbiology,and food laboratories around the world. Quality,reliability,service and support have been the company's guiding principles since our founding in 1955. Our innovative application of technology helps healthcare organizations improve the quality of care and industrial companies enhance quality and productivity. For more information,please visit aicompanies.com.
Media Contact:
Jon Flasher,Clinical Product Manager
jon.flasher@aicompanies.com
Photo - /up/2025/0206/25020620022127779058.jpg
Logo - /up/2025/0206/25020620022122154162.jpg
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map